Literature DB >> 29985566

A Double-Blind Placebo-Controlled Trial of Omega-3 Fatty Acids as a Monotherapy for Adolescent Depression.

Vilma Gabbay1,2,3, Rachel D Freed2, Carmen M Alonso2, Stefanie Senger4, Jill Stadterman2, Beth A Davison4, Rachel G Klein5.   

Abstract

OBJECTIVE: Reports are mixed on the efficacy of omega-3 fatty acids (O3FA) for the treatment of major depressive disorder (MDD), with only limited data in adolescents. The present trial aimed to investigate systematically the efficacy of O3FA as a monotherapy, compared to a placebo, in adolescents with MDD. Secondarily, we explored O3FA effects on anhedonia, irritability, and suicidality-all key features of adolescent MDD.
METHODS: Fifty-one psychotropic medication-free adolescents with DSM-IV-TR diagnoses of MDD (aged 12-19 years; 57% female) were randomized to receive O3FA or a placebo for 10 weeks. Data were collected between January 2006 and June 2013. O3FA and a placebo were administered on a fixed-flexible dose titration schedule based on clinical response and side effects. The initial dose of 1.2 g/d was increased 0.6 g/d every 2 weeks, up to a maximum of 3.6 g/d. Clinician-rated and self-rated depression severity, along with treatment response, served as primary outcome measures. Additionally, we examined O3FA effects on depression-related symptoms, including anhedonia, irritability, and suicidality. Treatment differences were analyzed via intent-to-treat analyses.
RESULTS: O3FA were not superior to a placebo on any clinical feature, including depression severity and levels of anhedonia, irritability, or suicidality. Additionally, response rates were comparable between treatment groups. Within-treatment analyses indicated that both treatments were associated with significant improvement in depression severity on self- (O3FA: t = -4.38, P < .001; placebo: t = -3.52, P = .002) and clinician (O3FA: t = -6.47, P < .001; placebo: t = -8.10, P < .001) ratings.
CONCLUSIONS: In adolescents with MDD, O3FA do not appear to be superior to placebo. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00962598. © Copyright 2018 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29985566      PMCID: PMC6625364          DOI: 10.4088/JCP.17m11596

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  71 in total

1.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

Authors:  J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

2.  Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia.

Authors:  Vilma Gabbay; Xiangling Mao; Rachel G Klein; Benjamin A Ely; James S Babb; Aviva M Panzer; Carmen M Alonso; Dikoma C Shungu
Journal:  Arch Gen Psychiatry       Date:  2011-10-03

3.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

4.  The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.

Authors:  Vilma Gabbay; Leonard Liebes; Yisrael Katz; Songtao Liu; Sandra Mendoza; James S Babb; Rachel G Klein; Oded Gonen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-09-21       Impact factor: 5.067

5.  The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial.

Authors:  Ellen L Mozurkewich; Chelsea M Clinton; Julie L Chilimigras; Susan E Hamilton; Lucy J Allbaugh; Deborah R Berman; Sheila M Marcus; Vivian C Romero; Marjorie C Treadwell; Kristie L Keeton; Anjel M Vahratian; Ronald M Schrader; Jianwei Ren; Zora Djuric
Journal:  Am J Obstet Gynecol       Date:  2013-04       Impact factor: 8.661

6.  A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression.

Authors:  Lauren B Marangell; James M Martinez; Holly A Zboyan; Barbara Kertz; H Florence Seung Kim; Lucy J Puryear
Journal:  Am J Psychiatry       Date:  2003-05       Impact factor: 18.112

7.  A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression.

Authors:  Vilma Gabbay; Rachel G Klein; Leah E Guttman; James S Babb; Carmen M Alonso; Melissa Nishawala; Yisrael Katz; Marta R Gaite; Charles J Gonzalez
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-08       Impact factor: 2.576

8.  Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.

Authors:  Anne M Libby; David A Brent; Elaine H Morrato; Heather D Orton; Richard Allen; Robert J Valuck
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

9.  Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.

Authors:  Giuseppe Grosso; Andrzej Pajak; Stefano Marventano; Sabrina Castellano; Fabio Galvano; Claudio Bucolo; Filippo Drago; Filippo Caraci
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

10.  Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.

Authors:  R J T Mocking; I Harmsen; J Assies; M W J Koeter; H G Ruhé; A H Schene
Journal:  Transl Psychiatry       Date:  2016-03-15       Impact factor: 6.222

View more
  11 in total

1.  Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.

Authors:  Robert K McNamara; Jeffrey R Strawn; Max J Tallman; Jeffrey A Welge; L Rodrigo Patino; Thomas J Blom; Melissa P DelBello
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-03-11       Impact factor: 2.576

Review 2.  Annual Research Review: Defining and treating pediatric treatment-resistant depression.

Authors:  Jennifer B Dwyer; Argyris Stringaris; David A Brent; Michael H Bloch
Journal:  J Child Psychol Psychiatry       Date:  2020-02-04       Impact factor: 8.982

Review 3.  Omega-3 fatty acids for depression in adults.

Authors:  Katherine M Appleton; Philip D Voyias; Hannah M Sallis; Sarah Dawson; Andrew R Ness; Rachel Churchill; Rachel Perry
Journal:  Cochrane Database Syst Rev       Date:  2021-11-24

Review 4.  Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature.

Authors:  Hans O Kalkman; Martin Hersberger; Suzanne Walitza; Gregor E Berger
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

5.  Omega-3 fatty acids for the treatment of depressive disorders in children and adolescents: a meta-analysis of randomized placebo-controlled trials.

Authors:  Li Zhang; Huan Liu; Li Kuang; Huaqing Meng; Xinyu Zhou
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2019-09-14       Impact factor: 3.033

6.  Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?

Authors:  Paola Bozzatello; Paola Rocca; Emanuela Mantelli; Silvio Bellino
Journal:  Int J Mol Sci       Date:  2019-10-23       Impact factor: 5.923

Review 7.  Novel Pharmacological Approaches to the Treatment of Depression.

Authors:  Elias Elias; Ariel Y Zhang; Melissa T Manners
Journal:  Life (Basel)       Date:  2022-01-28

8.  Experiences of adolescents and parents on the mental health management of depression in adolescents, North West province, South Africa.

Authors:  Precious C Chukwuere; Leepile A Sehularo; Mofatiki E Manyedi
Journal:  Curationis       Date:  2022-02-16

9.  Effects of Omega 3 Fatty Acids on Main Dimensions of Psychopathology.

Authors:  Paola Bozzatello; Maria Laura De Rosa; Paola Rocca; Silvio Bellino
Journal:  Int J Mol Sci       Date:  2020-08-21       Impact factor: 5.923

Review 10.  Effects of n-3 Polyunsaturated Fatty Acid Supplementation in the Prevention and Treatment of Depressive Disorders-A Systematic Review and Meta-Analysis.

Authors:  Maike Wolters; Annkathrin von der Haar; Ann-Kristin Baalmann; Maike Wellbrock; Thomas L Heise; Stefan Rach
Journal:  Nutrients       Date:  2021-03-25       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.